Merz Therapeutics buying two drugs for $185 million
One of the drugs is for the treatment of “off” phases of Parkinson’s disease called Inbrija. The other drug is for the treatment of gait disorders in multiple sclerosis called Ampyra.
Read More
drug design
AI system developed at UNC-CH may speed design of new drug candidates
An artificial intelligence system created at UNC-CH can design new drug candidates from scratch.
Read More
